Related Experiment Video

Updated: Aug 16, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

The quest for an HIV-1 therapeutic vaccine

Rajesh Tim Gandhi, Marcus Altfeld

    The Journal of Infectious Diseases
    |July 20, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
    06:07

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

    Published on: October 6, 2022

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
    14:23

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

    Published on: August 31, 2014

    Related Experiment Videos

    Last Updated: Aug 16, 2026

    Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
    12:03

    Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

    Published on: September 5, 2016

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
    06:07

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

    Published on: October 6, 2022

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
    14:23

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

    Published on: August 31, 2014

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

    Articles linked to this work by shared authors, journal, and citation graph.

    Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

    Structural modeling and functional characterization of a novel gain-of-function TLR8 variant causing severe inflammatory syndrome.

    JCI insight·2026

    Sex-Specific Factors Influencing HIV Infection.

    Immunological reviews·2026

    Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.

    British journal of pharmacology·2025

    HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production.

    iScience·2025

    The host cell factor DDX3 mediates sex dimorphism in the IFNα response of plasmacytoid dendritic cells upon TLR activation.

    Pharmacological research·2025

    Factors Associated with Persistently Increased IL-6 Levels in People with HIV.

    The Journal of infectious diseases·2026

    A Patient-Derived iPSC-Based Model Reveals Neural Lineage-Specific Transcription of Endogenous HHV-6B.

    The Journal of infectious diseases·2026

    Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption.

    The Journal of infectious diseases·2026

    Single-cell RNA sequencing reveals distinct immune interaction networks in primary and reactivated HHV-6B infection.

    The Journal of infectious diseases·2026

    Immune control of HIV viraemia in early paediatric infection is associated with induction of HIV-specific CD8+ T-cell activity following multiple treatment interruptions.

    The Journal of infectious diseases·2026

    Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.

    The Journal of infectious diseases·2026

    Interleukin-39 aggravates sepsis by inducing self-sustaining neutrophil activation in the lungs via the CXCL1-CXCR2 pathway.

    International journal of biological sciences·2026

    Mechanisms and clinical research progress of IL-6-mediated crosstalk between the alveolar microenvironment and the immune system in patients with severe pneumonia undergoing mechanical ventilation.

    Frontiers in immunology·2026

    Roles of IL-34 in neurological diseases: neuroprotection, inflammatory regulation, and myeloid plasticity.

    Frontiers in immunology·2026

    Inflammatory remodeling of the ovarian microenvironment in premature ovarian insufficiency: mechanisms and therapeutic opportunities.

    Frontiers in immunology·2026

    Recent understanding of immunometabolic remodeling in pulmonary macrophages: homeostasis, chronic respiratory diseases, and therapeutic targeting.

    Frontiers in pharmacology·2026

    RAC2 orchestrates immune cell actin remodeling and migration.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us